In a study by Vries et al (73), the growth of mouse breast tumors driven by HER2/neu resulted in the infiltration of intratumoral and systemic myeloid-derived suppressor cells (MDSCs), leading to immune escape and lack of systemic immunity. This evidence concerns the gene ERBB2 and breast neoplasm.